Share：
Share this content in WeChat
X
[Chinese][PDF]112070
• Review •
Manganese-based contrast agents for MRI
ZENG Qing-bin  GUO Qian-ni  LUO Qing  WU Guang-yao  ZHOU Xin 

DOI:10.3969/j.issn.1674-8034.2014.04.016.


[Abstract] It is always a challenge to keep improving the contrast of MRI (magnetic resonance imaging) for different tissues and organs in order to detect diseases. Contrast agents, which can enhance the relaxation of protons in water, are usually used to overcome such issue. Gadolinium-based complexes are the most predominantly used contrast agents owing to its good enhancement effect on the relaxation time, but they may be caused a serious disease called nephrogenic systemic fibrosis (NSF), so they have a limited use in vivo. Manganese is a non-lanthanide paramagnetic metal, and possess a good enhancement effect on the relaxation due to five unpaired electrons of bivalent manganese. Manganese-based contrast agents include manganese salts, small organic chelates, macromolecule chelates, oxide nanopaticles and so on. Manganese has also play essential roles in cell biology and very low toxic in vivo, which enables the usage with a large dose in MRI. This paper reviews the recent applications and comments the future outlook of manganese-based contrast agents for MRI.
[Keywords] Magnetic resonance imaging；Contrast media；Manganese compounds

ZENG Qing-bin Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, the Chinese Academy of Sciences, Wuhan 430071, China

GUO Qian-ni Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, the Chinese Academy of Sciences, Wuhan 430071, China

LUO Qing Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, the Chinese Academy of Sciences, Wuhan 430071, China

WU Guang-yao Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, the Chinese Academy of Sciences, Wuhan 430071, China

ZHOU Xin* Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, the Chinese Academy of Sciences, Wuhan 430071, China

*Correspondence to: Zhou X, Email: xinzhou@wipm.ac.cn

Conflicts of interest   None.

Received  2014-02-27
Accepted  2014-05-08
DOI: 10.3969/j.issn.1674-8034.2014.04.016
DOI:10.3969/j.issn.1674-8034.2014.04.016.

[1]
Lauterbur PC. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature, 1973, 242(5394): 190-191.
[2]
Mansfield P. Multi-planar image formation using NMR spin echoes. J Physics C: Solid State Physics, 1977, 10(3): L55-L58.
[3]
宋无名,陈南圭.功能MRI：最先进方法的简要回顾和展望.磁共振成像, 2013, 5(1): 361-372.
[4]
Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging, 1999, 10(3): 477-484.
[5]
鄢国平,卓仁禧.磁共振成像造影剂的研究进展.科学通报, 2001, 46(7): 531-538.
[6]
Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology, 2007, 242(3): 647-649.
[7]
Lin YJ, Koretsky AP. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med, 1997, 38(3): 378-388.
[8]
Bock NA, Paiva FF. Fractionated manganese-enhanced MRI. NMR Biomed, 2008, 21(5): 473-478.
[9]
Aoki I, Ebisu T, Naruse S, et al. Detection of the anoxic depolarization of focal ischemia using manganese-enhanced MRI. Magn Reson Med, 2003, 50(1): 7-12.
[10]
李英霞,方可,唐山民,等.以Mn2+为探针的磁共振分子影像技术.中国介入影像与治疗学, 2004, 1(1): 65-70.
[11]
Gutman DA, Magnuson M, Majeed W, et al. Mapping of the mouse olfactory system with manganese-enhanced magnetic resonance imaging and diffusion tensor imaging. Brain Struct Funct, 2013, 218(2): 527-537.
[12]
Elizaveta C, Vibeke L, Moller JM, et al. Imaging liver metastases with a new oral manganese-based contrast agent. Acad Radiology, 2006, 13(7): 827-832.
[13]
Antkowiak PF, Stevens BK, Nunemaker CS, et al. Manganese-enhanced magnetic resonance imaging detects declining pancreatic β-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes. Diabetes, 2013, 62(1): 44-48.
[14]
Schaefer S, Lange RA, Gutekunst DP, et al. Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Invest Radiology, 1991, 26(6): 551-556.
[15]
Troughton JS, Greenfield MT, Greenwood JM, et al. Synthesis and evaluation of a high relaxivity manganese (II)-based MRI contrast agent. Inorg Chem, 2004, 43(20): 6313-6323.
[16]
Zhang XA, Lovejoy KS, Jasanoff A, et al. Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc Natl Acad Sci U S A, 2007, 104(26): 10780-10785.
[17]
Lee T, Zhang XA, Dhar S, et al. In vivo Imaging with a cell-permeable porphyrin-based MRI contrast agent. Chem Biol, 2010, 17(6): 665-673.
[18]
Bertin A, Steibel J, Michou-Gallani AI, et al. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies. Bioconjugate chem, 2009, 20(4): 760-767.
[19]
Caravan P, Ellison JJ, McMurry TJ, et al. Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chemical Rev, 1999, 99(9): 2293-2352.
[20]
Zhang Z, He R, Yan K, et al. Synthesis and in vitro and in vivo evaluation of manganese (Ⅲ) porphyrin-dextran as a novel MRI contrast agent. Bioorg Med Chem Lett, 2009, 19(23): 6675-6678.
[21]
Sotak CH, Sharer K, Koretsky AP. Manganese cell labeling of murine hepatocytes using manganese (Ⅲ)-transferrin. Contrast Media Mol Imaging, 2008, 3(3): 95-105.
[22]
Geninatti CS, Cutrin JC, Lanzardo S, et al. Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. Contrast Media Mol Imaging, 2012, 7(3): 281-288.
[23]
Winter MB, Klemm PJ, Phillips-Piro CM, et al. Porphyrin-substituted H-NOX proteins as high-relaxivity MRI contrast agents. Inorg Chem, 2013, 52(5): 2277-2279.
[24]
Unger E, Fritz T, Kang S, et al. Manganese-based liposomes comparative approaches. Radiology, 1993, 28(10): 933-938.
[25]
Pan D, Caruthers SD, Hu G, et al. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. J Am Chem Soc, 2008, 130(29): 9186-9187.
[26]
Tan M, Wu X, Jeong EK, et al. An effective targeted nanoglobular manganese (II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Mol Pharm, 2010, 7(4): 936-943.
[27]
Tan M, Ye Z, Jeong EK, et al. Synthesis and evaluation of nanoglobular macrocyclic Mn (Ⅱ) chelate conjugates as non-gadolinium (Ⅲ) MRI contrast agents. Bioconjugate Chem, 2011, 22(5): 931-937.
[28]
Na HB, Lee JH, An K, et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem, 2007, 119(28): 5397-5401.
[29]
Kim T, Momin E, Choi J, et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose derived mesenchymal stem cells. J Am Chem Soc, 2011, 133(9): 2955-2961.
[30]
Xiao J, Tian XM, Yang C, et al. Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging. Sci Rep, 2013, 3: 3424.

PREV Kimura disease in the upper arm: a case report
NEXT A resting-state functional MRI study in Parkinson’s disease
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn